Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
...14 days until the deadline...
RC, this looks like a letter from Chris Stern to the shareholders. Did you get it through your e-mail?
interesting... scottrade shows bid at 0.26 and ask at 0.40...
fine, thanks for that. However the the most positive news we have been waiting for is the news about submittal of revised protocol to FDA. If they keep their promise, we should see something before the end of the year (we are in 35th day of fifty days time frame since the announcement on October 28th).
wiz, when I called company during transition phase and asked about the problems with the new website, I was told that indeed Mr. Abe was responsible for that...
well, looks like Abe got his act together - finally. This thing was promised few months back...
...with sort of anemic volume.
back to waiting game....
blimpy, your assumption is certainly twisted. You just simply assume that everybody here bought at around $1 (like yourself most probably) then sold at lower levels... Yes, if I sold in March I would have a profit of around 400%, but if I choose to sell right now I will still have a profit of 40%.
I like the possibility of immersing burned patients in the oxycyte tub...it is like science fiction coming to life...
Ham,
from the OXBO website:Oxygen Biotherapeutics, Inc. at Rodman & Renshaw Annual Global Investment Conference (Replay)
11/12/08 at 12:25 p.m. ET
BTW you can still listen to it...:)
Yes, this is the only news released today so far...
I am little bit surprised with the low volume after the news...
So far Obama factor seems to be working NOT in our favour...
BTW I checked the previous PRs about plans to file (04/04/08)and real filing of the protocol (04/14/08). So it took them 10 calendar days to file after the announcement. Lets see how it is going to work out this time.
Also, please remember about the possible financing from Europe...
We had two presentations this month in Switzerland. Lots of cards on the table....
on the positive note, I was just thinking that 50 days is a deadline by FDA to submit new protocol. Hopefully they will get their act together and submit earlier than that...and they know better what exactly FDA wants I hope...Just thinking out loud.
If I read this PR correctly, we can not anticipate anything to start in this year...:
1. 50 days (at least till end of the year) new protocol will be submitted
2. ??? days for FDA to approve or come up with some additional comments...
All I am saying is if you have been patient for last 8-10 years just do not sell now...we are looking at the time frame 6 months to a year when real thing start happening.
blimps, what "questionable activity" do you exactly have in mind?
OK guys, so now we need answers to the following questions:
1. when FDA approves "new" 40 patients study?
2. is this "new" study a replacement for the original 200 patients? Right now we only speculate(yes, no, maybe...)
Without FDA approval this smaller study can not start either...
Danmage, they do not mention November 12 as any affirmative date for any clarification. The only thing what is going to happen and we know about is a presentation in New York... Personally I am counting for some additional funding from Europe...
I see it this way. First thing in the morning when news occurred, there was some positive feedback from the market. Later on when some people digested the news and realized that they would have to wait another couple of months, they bailed out...
that is what I am saying exactly. This lack of official position from FDA is causing the little sell-off today.
bpmee, please remember that they were saying the same thing in June (i.e expecting), and we still do not have an official FDA approval. Without an approval you can not do any Phase II trials...
wiz, I do not agree. Since we still do not have an official FDA approval for Phase IIb or modified PhaseII, we are delayed, period.
...and for some impatient investors this next delay might be too much, so we might see us going down as well...
yes, another strike for Abe. This news has not shown up on the bigcharts.com...
This is overall great news, but what I miss in this PR is: "The protocol for phase IIb has been approved by the FDA". That would make difference. I am not being negative, just can't wait to see this approval official...
charlie and damage - there are only two possible scenarios in this market. With approval we will go sharply higher, and (god forbids) with next delay we will go sharply lower.I am not going to speculate how high or how low we will go...
no mil today, but 600k+ ain't bad...
Damage, we already have some appetizer as far the craziness is concerned...Today we swung from 0.42 to 0.5 with volume 400k. We might touch 1 mil as well...:)
Two mentions from raging bull OXBO page (both refer to quote.com):
* Wall Street News Alert: Hot Stocks in Focus! October 16, 2008
09:32:00 EDT
* Pinnacle Digest: Oxygen Biotherapeutics Draws Interest From Leading Online Investment Magazine
04:18:00 EDT
well, the second presentation in Switzerland is over. Let's see if there is some financial fallout from these events...
freak - they have done it before, few years ago. Nickora was doing this. Now we have much more to offer I think, so it makes more sense to present...:)
looks like we have some selling pressure...
this week is another presentation in Europe...
exactly ham - the volume is kind of regular today. I would not call it heavy for sure.
Also if I am not mistaken, the short selling restrictions were lifted yesterday...
day trading in full bloom...
james, I would agree - this is not panic selling (we would have volume exceeding 1 million). This is strictly MMs game...
Also please remember the second presentation in Europe on October 15th...